Marie‐Emilie Willemin

Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug–Drug Interactions

Marie‐Emilie Willemin, Thomas K. van der Made, Ils Pijpers et al. · Clinical Pharmacokinetics · 2021 · 46 citations · Full text

Molecular Pharmacology, Endogenous Biomarkers, Biomarker (Medicine) +6

PBPK modeling of the cis- and trans-permethrin isomers and their major urinary metabolites in rats

Marie‐Emilie Willemin, Sophie Desmots, R. Le Grand et al. · Toxicology and Applied Pharmacology · 2016 · 31 citations · Full text

Biochemistry, Major Urinary Metabolites, Medicine +9

Determination of cis-permethrin, trans-permethrin and associated metabolites in rat blood and organs by gas chromatography–ion trap mass spectrometry

François Lestremau, Marie‐Emilie Willemin, Claudine Chatellier et al. · Analytical and Bioanalytical Chemistry · 2014 · 25 citations · Full text

Biochemistry, Medicine, Bioanalysis +10

Development of 4‐Pyridoxic Acid PBPK Model to Support Biomarker‐Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease

Shawn Pei Feng Tan, Marie‐Emilie Willemin, Jan Snoeys et al. · Clinical Pharmacology & Therapeutics · 2023 · 21 citations · Full text

Endogenous Biomarkers, Renal Pathology, Renal Inflammation +17

In vitro human metabolism of permethrin isomers alone or as a mixture and the formation of the major metabolites in cryopreserved primary hepatocytes

Marie‐Emilie Willemin, András Kádár, Georges de Sousa et al. · Toxicology in Vitro · 2015 · 18 citations

Biochemistry, Medicine, Liver Physiology +15